Related references
Note: Only part of the references are listed.2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC)
Borja Ibanez et al.
EUROPEAN HEART JOURNAL (2018)
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS
Marco Valgimigli et al.
EUROPEAN HEART JOURNAL (2018)
The quest for safer antithrombotic treatment regimens in patients with coronary artery disease: new strategies and paradigm shifts
Jae Youn Moon et al.
EXPERT REVIEW OF HEMATOLOGY (2018)
Oral anti-Xa anticoagulation after trans-aortic valve implantation for aortic stenosis: The randomized ATLANTIS trial
Jean-Philippe Collet et al.
AMERICAN HEART JOURNAL (2018)
ASCEND: A Study of Cardiovascular Events iN Diabetes: Characteristics of a randomized trial of aspirin and of omega-3 fatty acid supplementation in 15,480 people with diabetes
Louise Bowman et al.
AMERICAN HEART JOURNAL (2018)
Evaluation of the safety and efficacy of an edoxaban-based antithrombotic regimen in patients with atrial fibrillation following successful percutaneous coronary intervention (PCI) with stent placement: Rationale and design of the ENTRUST-AF PCI trial
Pascal Vranckx et al.
AMERICAN HEART JOURNAL (2018)
An open-Label, 2 x 2 factorial, randomized controlled trial to evaluate the safety of apixaban vs. vitamin K antagonist and aspirin vs. placebo in patients with atrial fibrillation and acute coronary syndrome and/or percutaneous coronary intervention: Rationale and design of the AUGUSTUS trial
Renato D. Lopes et al.
AMERICAN HEART JOURNAL (2018)
Meta-Analysis Comparing the Safety and Efficacy of Dual Versus Triple Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
Ilaria Cavallari et al.
AMERICAN JOURNAL OF CARDIOLOGY (2018)
Aspirin in Patients With Previous Percutaneous Coronary Intervention Undergoing Noncardiac Surgery
Michelle M. Graham et al.
ANNALS OF INTERNAL MEDICINE (2018)
2018 Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology Focused Update of the Guidelines for the Use of Antiplatelet Therapy
Shamir R. Mehta et al.
CANADIAN JOURNAL OF CARDIOLOGY (2018)
Advances in atherosclerosis, atrial fibrillation, and valvular disease
Deepak L. Bhatt
NATURE REVIEWS CARDIOLOGY (2018)
Current and future antiplatelet therapies: emphasis on preserving haemostasis
James D. McFadyen et al.
NATURE REVIEWS CARDIOLOGY (2018)
Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention: A North American Perspective-2018 Update
Dominick J. Angiolillo et al.
CIRCULATION (2018)
Recurrent Hospitalization Among Patients With Atrial Fibrillation Undergoing Intracoronary Stenting Treated With 2 Treatment Strategies of Rivaroxaban or a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy
C. Michael Gibson et al.
CIRCULATION (2017)
Thrombo-embolic prevention after transcatheter aortic valve implantation
Pascal Vranckx et al.
EUROPEAN HEART JOURNAL (2017)
Aspirin Versus Aspirin Plus Clopidogrel as Antithrombotic Treatment Following Transcatheter Aortic Valve Replacement With a Balloon-Expandable Valve The ARTE (Aspirin Versus Aspirin plus Clopidogrel Following Transcatheter Aortic Valve Implantation) Randomized Clinical Trial
Josep Rodes-Cabau et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2017)
Antithrombotic Therapy for Prevention of Cerebral Thromboembolic Events After Transcatheter Aortic Valve Replacement Evolving Paradigms and Ongoing Directions
Davide Capodanno et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2017)
Enteric Coating and Aspirin Nonresponsiveness in Patients With Type 2 Diabetes Mellitus
Deepak L. Bhatt et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial
E. Magnus Ohman et al.
LANCET (2017)
Single or dual antiplatelet therapy after PCI
Yosuke Miyazaki et al.
NATURE REVIEWS CARDIOLOGY (2017)
Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease
J. W. Eikelboom et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Ticagrelor versus Clopidogrel in Symptomatic Peripheral Artery Disease
William R. Hiatt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation
Christopher P. Cannon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Oral antithrombotic therapy after acute coronary syndromes: dual antiplatelet or dual pathway?
Davide Capodanno
EUROINTERVENTION (2017)
Low-Dose Aspirin Discontinuation and Risk of Cardiovascular Events A Swedish Nationwide, Population-Based Cohort Study
Johan Sundstroem et al.
CIRCULATION (2017)
Safety and Efficacy of Dual Versus Triple Antithrombotic Therapy in Patients Undergoing Percutaneous Coronary Intervention
Nayan Agarwal et al.
AMERICAN JOURNAL OF MEDICINE (2017)
The aspirin story - from willow to wonder drug
Michael J. R. Desborough et al.
BRITISH JOURNAL OF HAEMATOLOGY (2017)
Trial design: Rivaroxaban for the prevention of major cardiovascular events after transcatheter aortic valve replacement: Rationale and design of the GALILEO study
Stephan Windecker et al.
AMERICAN HEART JOURNAL (2017)
Inhibition of the platelet P2Y12 receptor for adenosine diphosphate does not impair the capacity of platelet to synthesize thromboxane A2
Mariangela Scavone et al.
EUROPEAN HEART JOURNAL (2016)
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC)
Marco Roffi et al.
EUROPEAN HEART JOURNAL (2016)
Inter-patient variability of platelet reactivity in patients treated with prasugrel and ticagrelor
Jolanta M. Siller-Matula et al.
PLATELETS (2016)
Ticagrelor with aspirin or alone in high-risk patients after coronary intervention: Rationale and design of the TWILIGHT study
Usman Baber et al.
AMERICAN HEART JOURNAL (2016)
Rationale and design of POPular-TAVI: antiPlatelet therapy fOr Patients undergoing Transcatheter Aortic Valve Implantation
Vincent Johan Nijenhuis et al.
AMERICAN HEART JOURNAL (2016)
Aspirin for the Prevention of Cancer Incidence and Mortality: Systematic Evidence Reviews for the US Preventive Services Task Force
Jessica Chubak et al.
ANNALS OF INTERNAL MEDICINE (2016)
Aspirin for the Primary Prevention of Cardiovascular Events: A Systematic Evidence Review for the US Preventive Services Task Force
Janelle M. Guirguis-Blake et al.
ANNALS OF INTERNAL MEDICINE (2016)
Bleeding Risks With Aspirin Use for Primary Prevention in Adults: A Systematic Review for the US Preventive Services Task Force
Evelyn P. Whitlock et al.
ANNALS OF INTERNAL MEDICINE (2016)
Aspirin Use for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer: US Preventive Services Task Force Recommendation Statement
Kirsten Bibbins-Domingo
ANNALS OF INTERNAL MEDICINE (2016)
Pharmacodynamic Comparison of Prasugrel Versus Ticagrelor in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease The OPTIMUS (Optimizing Antiplatelet Therapy in Diabetes Mellitus)-4 Study
Francesco Franchi et al.
CIRCULATION (2016)
A Critical Appraisal of Aspirin in Secondary Prevention: Is Less More?
Giuseppe Gargiulo et al.
CIRCULATION (2016)
Aspirin for Primary Cardiovascular Risk Prevention and Beyond in Diabetes Mellitus
Davide Capodanno et al.
CIRCULATION (2016)
Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention A North American Perspective-2016 Update
Dominick J. Angiolillo et al.
CIRCULATION-CARDIOVASCULAR INTERVENTIONS (2016)
ADD-ASPIRIN: A phase III, double-blind, placebo controlled, randomised trial assessing the effects of aspirin on disease recurrence and survival after primary therapy in common non-metastatic solid tumours
Christopher Coyle et al.
CONTEMPORARY CLINICAL TRIALS (2016)
2016 European Guidelines on cardiovascular disease prevention in clinical practice
Massimo F. Piepoli et al.
EUROPEAN HEART JOURNAL (2016)
Aspirin and Cancer
Paola Patrignani et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Prosthetic Heart Valve Thrombosis
George D. Dangas et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Platelet Inhibition With Ticagrelor 60 mg Versus 90 mg Twice Daily in the PEGASUS-TIMI 54 Trial
Robert F. Storey et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease
Glenn N. Levine et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2016)
Effects of P2Y12 receptor inhibition with or without aspirin on hemostatic system activation: a randomized trial in healthy subjects
L. Traby et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2016)
Antithrombotic therapy for secondary prevention of atherothrombotic events in cerebrovascular disease
Davide Capodanno et al.
NATURE REVIEWS CARDIOLOGY (2016)
Ticagrelor versus Aspirin in Acute Stroke or Transient Ischemic Attack
S. Claiborne Johnston et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI
C. Michael Gibson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Long-term ticagrelor monotherapy versus standard dual antiplatelet therapy followed by aspirin monotherapy in patients undergoing biolimus-eluting scent implantation: rationale and design of the GLOBAL LEADERS trial
Pascal Vranckx et al.
EUROINTERVENTION (2016)
The ADAPTABLE Trial and Aspirin Dosing in Secondary Prevention for Patients with Coronary Artery Disease
Abigail Johnston et al.
CURRENT CARDIOLOGY REPORTS (2016)
Extended-release acetylsalicylic acid for secondary prevention of stroke and cardiovascular events
Kevin P. Bliden et al.
EXPERT REVIEW OF CARDIOVASCULAR THERAPY (2016)
Effects of Rivaroxaban on Platelet Activation and Platelet-Coagulation Pathway Interaction: In Vitro and In Vivo Studies
Elisabeth Perzborn et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS (2015)
The Multifaceted Clinical Readouts of Platelet Inhibition by Low-Dose Aspirin
Carlo Patrono
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction
Marc P. Bonaca et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Usefulness and Safety of Vorapaxar in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention (from the TRACER Trial)
Marco Valgimigli et al.
AMERICAN JOURNAL OF CARDIOLOGY (2014)
2014 AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
Ezra A. Amsterdam et al.
CIRCULATION (2014)
2014 ESC/EACTS Guidelines on myocardial revascularization
Stephan Windecker et al.
EUROPEAN HEART JOURNAL (2014)
Causes of mortality with ticagrelor compared with clopidogrel in acute coronary syndromes
Christoph Varenhorst et al.
HEART (2014)
Adenosine-Mediated Effects of Ticagrelor Evidence and Potential Clinical Relevance
Marco Cattaneo et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials
Christian T. Ruff et al.
LANCET (2014)
Lower mortality following pulmonary adverse events and sepsis with ticagrelor compared to clopidogrel in the PLATO study
Robert F. Storey et al.
PLATELETS (2014)
Targeting factor Xa and thrombin: impact on coagulation and beyond
Charles T. Esmon
THROMBOSIS AND HAEMOSTASIS (2014)
Cigarette Smoking and Antiplatelet Effects of Aspirin Monotherapy Versus Clopidogrel Monotherapy in Patients with Atherosclerotic Disease: Results of a Prospective Pharmacodynamic Study
Fabiana Rollini et al.
JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH (2014)
Updates on NSAIDs in patients with and without coronary artery disease: pitfalls, interactions and cardiovascular outcomes
Giuseppe Gargiulo et al.
EXPERT REVIEW OF CARDIOVASCULAR THERAPY (2014)
2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
Patrick T. O'Gara et al.
CIRCULATION (2013)
Study design of ASPirin in Reducing Events in the Elderly (ASPREE): A randomized, controlled trial
R. H. Grimm et al.
CONTEMPORARY CLINICAL TRIALS (2013)
2013 ESC guidelines on the management of stable coronary artery disease
Gilles Montalescot et al.
EUROPEAN HEART JOURNAL (2013)
Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial
Willem J. M. Dewilde et al.
LANCET (2013)
Prasugrel versus clopidogrel for patients with unstable angina or non-ST-segment elevation myocardial infarction with or without angiography: a secondary, prespecified analysis of the TRILOGY ACS trial
Stephen D. Wiviott et al.
LANCET (2013)
Evaluation of the pharmacokinetics and pharmacodynamics of ticagrelor co-administered with aspirin in healthy volunteers
Renli Teng et al.
PLATELETS (2013)
Impact of aspirin dose on adenosine diphosphate-mediated platelet activities Results of an in vitro pilot investigation
Antonio Tello-Montoliu et al.
THROMBOSIS AND HAEMOSTASIS (2013)
2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons
Stephan D. Fihn et al.
CIRCULATION (2012)
Effects of rivaroxaban, acetylsalicylic acid and clopidogrel as monotherapy and in combination in a porcine model of stent thrombosis
E. M. Becker et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2012)
Prasugrel versus Clopidogrel for Acute Coronary Syndromes without Revascularization
Matthew T. Roe et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Rivaroxaban in Patients with a Recent Acute Coronary Syndrome
Jessica L. Mega et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes
Pierluigi Tricoci et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Vorapaxar in the Secondary Prevention of Atherothrombotic Events
David A. Morrow et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Ticagrelor Compared With Clopidogrel by Geographic Region in the Platelet Inhibition and Patient Outcomes (PLATO) Trial
Kenneth W. Mahaffey et al.
CIRCULATION (2011)
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: Executive Summary A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions
Glenn N. Levine et al.
CIRCULATION (2011)
AHA/ACCF Secondary Prevention and Risk REduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease: 2011 Update - A Guideline from the American Heart Association and American College of Cardiology Foundation
Sidney C. Smith et al.
CIRCULATION (2011)
Diabetes and Antiplatelet Therapy in Acute Coronary Syndrome
Jose Luis Ferreiro et al.
CIRCULATION (2011)
Pharmacodynamic Effects of Different Aspirin Dosing Regimens in Type 2 Diabetes Mellitus Patients With Coronary Artery Disease
Davide Capodanno et al.
CIRCULATION-CARDIOVASCULAR INTERVENTIONS (2011)
In the presence of strong P2Y12 receptor blockade, aspirin provides little additional inhibition of platelet aggregation
P. C. J. Armstrong et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2011)
Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double-blind, parallel-group trial
Marie-Germaine Bousser et al.
LANCET (2011)
Apixaban in Patients with Atrial Fibrillation
Stuart J. Connolly et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Apixaban with Antiplatelet Therapy after Acute Coronary Syndrome
John H. Alexander et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Platelet thrombin receptor antagonism and atherothrombosis
Dominick J. Angiolillo et al.
EUROPEAN HEART JOURNAL (2010)
Reduction of platelet thromboxane A(2) production ex vivo and in vivo by clopidogrel therapy
P. C. J. Armstrong et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial
Shamir R. Mehta et al.
LANCET (2010)
Dose Comparisons of Clopidogrel and Aspirin in Acute Coronary Syndromes
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Platelet Adenosine Diphosphate P2Y(12) Receptor Antagonism: Benefits and Limitations of Current Treatment Strategies and Future Directions
Dominick J. Angiolillo et al.
REVISTA ESPANOLA DE CARDIOLOGIA (2010)
Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel, and vitamin K antagonists in Denmark: a retrospective analysis of nationwide registry data
Rikke Sorensen et al.
LANCET (2009)
Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials
LANCET (2009)
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
Lars Wallentin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Effect of Clopidogrel Added to Aspirin in Patients with Atrial Fibrillation
S. J. Connolly et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Impact of P2Y12 Inhibitory Effects Induced by Clopidogrel on Platelet Procoagulant Activity in Type 2 Diabetes Mellitus Patients
Dominick J. Angiolillo et al.
THROMBOSIS RESEARCH (2009)
Aspirin: Promise and resistance in the new millennium
Carlo Patrono et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Prasugrel versus clopidogrel in patients with acute coronary syndromes
Stephen D. Wiviott et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Aspirin and Simvastatin Combination for Cardiovascular Events Prevention Trial in Diabetes (ACCEPT- D): Design of a randomized study of the efficacy of low-dose aspirin in the prevention of cardiovascular events in subjects with diabetes mellitus treated with statins
Giorgia De Berardis et al.
TRIALS (2007)
Evaluation of dose-related effects of aspirin on platelet function - Results from the aspirin-induced platelet effect (ASPECT) study
Paul A. Gurbel et al.
CIRCULATION (2007)
Meta-analysis: Antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation
Robert G. Hart et al.
ANNALS OF INTERNAL MEDICINE (2007)
Variability in individual responsiveness to clopidogrel - Clinical implications, management, and future perspectives
Dominick J. Angiolillo et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial
S. Connolly et al.
LANCET (2006)
Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events
DL Bhatt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Biology and pharmacology of the platelet P2Y(12) receptor
Robert F. Storey
CURRENT PHARMACEUTICAL DESIGN (2006)
Drug therapy -: Low-dose aspirin for the prevention of atherothrombosis
C Patrono et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial
ZM Chen et al.
LANCET (2005)
Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation
MS Sabatine et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Benefit of clopidogrel over aspirin is amplified in patients with a history of ischemic events
PA Ringleb et al.
STROKE (2004)
Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial
HC Diener et al.
LANCET (2004)
Comparative benefits of clopidogrel and aspirin in high-risk patient populations
J Hirsh et al.
ARCHIVES OF INTERNAL MEDICINE (2004)
The discovery of the antiplatelet effect of aspirin: a personal reminiscence
HJ Weiss
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2003)
Two waves of platelet secretion induced by thromboxane A2 receptor and a critical role for phosphoinositide 3-kinases
ZY Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention - A randomized controlled trial
SR Steinhubl et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Early potent antithrombotic effect with combined aspirin and a loading dose of clopidogrel on experimental arterial thrombogenesis in humans
Y Cadroy et al.
CIRCULATION (2000)
The central role of the P-2T receptor in amplification of human platelet activation, aggregation, secretion and procoagulant activity
RF Storey et al.
BRITISH JOURNAL OF HAEMATOLOGY (2000)
Share Paper
